Login to Your Account



Nastech Brings In $23M To Support PTH Nasal Program

By Karen Pihl-Carey


Friday, August 26, 2005
Only a few weeks after withdrawing one public offering due to market conditions, Nastech Pharmaceutical Company Inc. did a complete turnaround, pricing more than 1.7 million shares on Thursday to raise $23.3 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription